Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.

our clients
tiltle-brk

client-logo
client-logo2
client-logo3
client-logo4
client-logo
client-logo
client-logo
client-logo

"The quality of representation was outstanding. I never thought that understanding a complex market can be that much easy"

Adam Smith, Associate Director, Bain Capital

"More than just selling a report, the team was more focused towards the understanding of my requirements. Regular updation was the best part."

Koh Vivian, Product Development Manager, Swiss Bio Pharma

"Hats off to expert analysis, the team was very supporting and thanks for not charging me on additional data."

Erin Green, Director, Green Energy Consulting

" I really want to thank Goldstein Research for their efforts to make my project successful. F2F discussion with the market experts was excellent. Keep up the good work guyz "

Jorge Foyo, , Analyst, BCG
Market Research Report

Endocrine Testing Market: By Technology (Tandem Mass Spectrometry, Immunoassay, Monoclonal, Sensor & Clinical Chemistry Technologies), By Disorder Categories, By End User

Published On : 2018-10-15 Report Page : 310 Category: Healthcare

Endocrine Testing Market in the Global Industry Landscape

Endocrine testing is done to get information related to the hormone level in the body the disorders related to them. In the past years, the elucidation of the pathophysiology related to several endocrine disorders is successful through the development of radio-immunoassay and various other diagnostic tools. This has led the clinicians to make faster and accurate diagnosis. The diseases such as thyroid disorders, osteoporosis, diabetes, and hyperparathyroidism which tends to increase their frequency with the advent of age and other factors are the ones most benefitted with the new technologies. Moreover, the effective and specific cure therapies such as the oral sulfonylureas for both hormonal and non-hormonal treatments for osteoporosis and also diabetes have certainly enhanced the quality and longevity of life of older individuals suffering from these diseases. The newer tests varieties provides the ability to monitor the therapeutic effectiveness from a closer view.

Our Global Endocrine Testing Market can be segmented on the following basis:

Based on Technology

  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal and Polyclonal Antibody Technologies
  • Sensor Technologies
  • Clinical Chemistry Technologies

Based on Disorder Categories

  • Adrenocortical Function
  • Perturbation Tests
  • Diagnostic Profiles
  • Thyroid Function
  • Hypothalamic and Pituitary Function
  • Growth and Growth Hormone
  • Metabolic and Gastrointestinal Disorders
  • Others (Gonadal Function, etc.)

Based on End User

  • Hospitals/Critical Care Centers
  • Diagnostics Labs
  • Research Laboratories

By Geography

  • North America (US, Canada) {Market Share (%), Market Size (USD Billion)} Endocrine Testing Market
  • Europe (UK, France, Italy, Germany, Spain, Sweden, Russia, Netherlands, Norway and Rest of Europe) {Market Share (%), Market Size (USD Billion)} Endocrine Testing Industry
  • The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion)} Endocrine Testing Market
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion)} Endocrine Testing Market
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion)} Endocrine Testing Market

Global Endocrine Testing Market Outlook comprises of the following data:

  • Endocrine testing market size and market compounded annual growth rate, 2017-2025
  • Number of endocrine testing cases by region, 2017-2025
  • Number of New Entrants in the endocrine testing market, 2017-2025
  • Number of new clinically tested and approved endocrine tests types, 2017-2018

North America endocrine testing market is the leading the way in terms of revenue generation. The high healthcare investments in the region coupled with positive regulatory framework and high reimbursement scenario are the major driving factors for the growth of endocrine testing market in North America.

The U.S. Food and Drug Administration (FDA) in early 2018 approved a new continuous glucose monitoring (CGM) system applicable for diabetic people between the age group of 14 to 75 years. The company Medtronic, is witnessed to market the system with a name as ‘Guardian Connect’, globally the first smart system that can help diabetic people to keep a real-time track of high and low glucose events and stay proactive. The Guardian Connect system has helped the people indulged with multiple daily injections (MDI) towards more actively and preemptively manage their diabetes.

Expert Analysis: Various endocrine testing technologies are under trial to treat hormonal disorders. Development of new test methods has undergone intensive research over the past decade. And still the developers are addressing the question that whether the system is capable of resolving complexities of the endocrine system as per the regulatory health and ecological risk assessments.


Global Endocrine Testing Market -Table of Contents

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Data Analyzing &Market Size Estimation 
1.4. Research Design
1.5. Bottom-Up & Top-Down Approach
 
2. Market Environment
2.1. Global Economic Overview
2.2. Macroeconomic Outlook
2.3. Healthcare Industry Outlook
2.4. Healthcare Devices Technology Outlook
2.5. Medical Diagnosis Market Analysis
2.6. Common Allergens Scenario Analysis
2.7. Endocrine Disorder Scenario Analysis
2.8. Demographic Trends Analysis 
2.9. Regulatory Considerations 
 
3. Industry Structure
3.1. Target Consumer Group Analysis
3.2. Target Markets (By Countries)
3.3. Research & Development Outlook
3.4. Investments Outlook
3.5. Competitive Strategies
3.6. Acquisitions & Divestitures
 
4. Executive Summary
4.1. Market Size (USD Million)
4.2. Forecast Analysis (2017-2025)
4.3. Market Share & CAGR (%)
4.4. Regional Share Distribution (%)
 
5. Market Dynamics
5.1. Growth Drivers
5.2. Market Restraints
5.3. Risk Analysis (Demand Risk & Supply Risk Analysis)
5.4. Recent Trends & Developments
5.5. Opportunities for Market Players
 
6. Endocrine Testing Market Segmentation Analysis, 2017-2025
 
6.1. Global Endocrine Testing Market Analysis, By Technology 
6.1.1. Tandem Mass Spectrometry 
6.1.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.1.1.2. Y-o-Y Growth (%), 2017-2025
6.1.1.3. Market Share (%), 2017-2025
6.1.2. Immunoassay
6.1.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.1.2.2. Y-o-Y Growth (%), 2017-2025
6.1.2.3. Market Share (%), 2017-2025
6.1.3. Monoclonal and Polyclonal Antibody Technologies
6.1.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.1.3.2. Y-o-Y Growth (%), 2017-2025
6.1.3.3. Market Share (%), 2017-2025
6.1.4. Sensor Technologies
6.1.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.1.4.2. Y-o-Y Growth (%), 2017-2025
6.1.4.3. Market Share (%), 2017-2025
6.1.5. Clinical Chemistry Technologies
6.1.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.1.5.2. Y-o-Y Growth (%), 2017-2025
6.1.5.3. Market Share (%), 2017-2025
6.1.6. BPS Analysis of Endocrine Testing Market By Technology
6.1.7. Market Attractiveness of Endocrine Testing MarketBy Technology
 
6.2. Global Endocrine Testing Market Analysis, By Disorder Categories
6.2.1. Adrenocortical Function
6.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.2.1.2. Y-o-Y Growth (%), 2017-2025
6.2.1.3. Market Share (%), 2017-2025
6.2.2. Perturbation Tests
6.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.2.2.2. Y-o-Y Growth (%), 2017-2025
6.2.2.3. Market Share (%), 2017-2025
6.2.3. Diagnostic Profiles
6.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.2.3.2. Y-o-Y Growth (%), 2017-2025
6.2.3.3. Market Share (%), 2017-2025
6.2.4. Thyroid Function
6.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.2.4.2. Y-o-Y Growth (%), 2017-2025
6.2.4.3. Market Share (%), 2017-2025
6.2.5. Hypothalamic and Pituitary Function
6.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.2.5.2. Y-o-Y Growth (%), 2017-2025
6.2.5.3. Market Share (%), 2017-2025
6.2.6. Growth and Growth Hormone
6.2.6.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.2.6.2. Y-o-Y Growth (%), 2017-2025
6.2.6.3. Market Share (%), 2017-2025
6.2.7. Metabolic and Gastrointestinal Disorders
6.2.7.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.2.7.2. Y-o-Y Growth (%), 2017-2025
6.2.7.3. Market Share (%), 2017-2025
6.2.8. BPS Analysis of Endocrine Testing Market By Disorder Categories
6.2.9. Market Attractiveness of Endocrine Testing Market By Disorder Categories
 
6.3. Global Endocrine Testing Market Analysis, By End Users 
6.3.1. Hospitals/Critical Care Centers
6.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.3.1.2. Y-o-Y Growth (%), 2017-2025
6.3.1.3. Market Share (%), 2017-2025
6.3.2. Diagnostics Labs
6.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.3.2.2. Y-o-Y Growth (%), 2017-2025
6.3.2.3. Market Share (%), 2017-2025
6.3.3. Research Laboratories
6.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.3.3.2. Y-o-Y Growth (%), 2017-2025
6.3.3.3. Market Share (%), 2017-2025
6.3.4. BPS Analysis of Endocrine Testing Market By End User
6.3.5. Market Attractiveness of Endocrine Testing MarketBy End User
 
6.4. Global Endocrine Testing Market Outlook, By Region, 2017-2025
 
6.4.1. North America Endocrine Testing Market Outlook, 2017-2025
 
6.4.1.1. North America Endocrine Testing Market Analysis, By Country
6.4.1.1.1. U.S. Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.1.1.2.  Canada Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.1.1.3. BPS Analysis of Endocrine Testing Market By Country
6.4.1.1.4. Market Attractiveness of Endocrine Testing MarketBy Country
 
6.4.1.2. North America Endocrine Testing Market Analysis, By Technology 
6.4.1.2.1. Tandem Mass Spectrometry 
6.4.1.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.2.1.2. Y-o-Y Growth (%), 2017-2025
6.4.1.2.1.3. Market Share (%), 2017-2025
6.4.1.2.2. Immunoassay
6.4.1.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.2.2.2. Y-o-Y Growth (%), 2017-2025
6.4.1.2.2.3. Market Share (%), 2017-2025
6.4.1.2.3. Monoclonal and Polyclonal Antibody Technologies
6.4.1.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.2.3.2. Y-o-Y Growth (%), 2017-2025
6.4.1.2.3.3. Market Share (%), 2017-2025
6.4.1.2.4. Sensor Technologies
6.4.1.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.2.4.2. Y-o-Y Growth (%), 2017-2025
6.4.1.2.4.3. Market Share (%), 2017-2025
6.4.1.2.5. Clinical Chemistry Technologies
6.4.1.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.2.5.2. Y-o-Y Growth (%), 2017-2025
6.4.1.2.5.3. Market Share (%), 2017-2025
6.4.1.2.6. BPS Analysis of Endocrine Testing Market By Technology
6.4.1.2.7. Market Attractiveness of Endocrine Testing MarketBy Technology
 
6.4.1.3. North America Endocrine Testing Market Analysis, By Disorder Categories
6.4.1.3.1. Adrenocortical Function
6.4.1.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.3.1.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3.1.3. Market Share (%), 2017-2025
6.4.1.3.2. Perturbation Tests
6.4.1.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.3.2.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3.2.3. Market Share (%), 2017-2025
6.4.1.3.3. Diagnostic Profiles
6.4.1.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.3.3.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3.3.3. Market Share (%), 2017-2025
6.4.1.3.4. Thyroid Function
6.4.1.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.3.4.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3.4.3. Market Share (%), 2017-2025
6.4.1.3.5. Hypothalamic and Pituitary Function
6.4.1.3.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.3.5.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3.5.3. Market Share (%), 2017-2025
6.4.1.3.6. Growth and Growth Hormone
6.4.1.3.6.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.3.6.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3.6.3. Market Share (%), 2017-2025
6.4.1.3.7. Metabolic and Gastrointestinal Disorders
6.4.1.3.7.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.3.7.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3.7.3. Market Share (%), 2017-2025
6.4.1.3.8. BPS Analysis of Endocrine Testing Market By Disorder Categories
6.4.1.3.9. Market Attractiveness of Endocrine Testing Market By Disorder Categories
 
6.4.1.4. North America Endocrine Testing Market Analysis, By End Users 
6.4.1.4.1. Hospitals/Critical Care Centers
6.4.1.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.4.1.2. Y-o-Y Growth (%), 2017-2025
6.4.1.4.1.3. Market Share (%), 2017-2025
6.4.1.4.2. Diagnostics Labs
6.4.1.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.4.2.2. Y-o-Y Growth (%), 2017-2025
6.4.1.4.2.3. Market Share (%), 2017-2025
6.4.1.4.3. Research Laboratories
6.4.1.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.1.4.3.2. Y-o-Y Growth (%), 2017-2025
6.4.1.4.3.3. Market Share (%), 2017-2025
6.4.1.4.4. BPS Analysis of Endocrine Testing Market By End User
6.4.1.4.5. Market Attractiveness of Endocrine Testing MarketBy End User
 
6.4.2. Europe Endocrine Testing Market Outlook, 2017-2025
 
6.4.2.1. Europe Endocrine Testing Market Analysis, By Country
6.4.2.1.1. UK Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.2.  Germany Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.3.  France Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.4.  Italy Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.5.  Spain Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.6.  BENELUX Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.7.  Russia Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.8.  Sweden Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.9. Rest of Europe Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.2.1.10. BPS Analysis of Endocrine Testing Market By Country
6.4.2.1.11. Market Attractiveness of Endocrine Testing MarketBy Country
 
6.4.2.2. Europe Endocrine Testing Market Analysis, By Technology 
6.4.2.2.1. Tandem Mass Spectrometry 
6.4.2.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.2.1.2. Y-o-Y Growth (%), 2017-2025
6.4.2.2.1.3. Market Share (%), 2017-2025
6.4.2.2.2. Immunoassay
6.4.2.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.2.2.2. Y-o-Y Growth (%), 2017-2025
6.4.2.2.2.3. Market Share (%), 2017-2025
6.4.2.2.3. Monoclonal and Polyclonal Antibody Technologies
6.4.2.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.2.3.2. Y-o-Y Growth (%), 2017-2025
6.4.2.2.3.3. Market Share (%), 2017-2025
6.4.2.2.4. Sensor Technologies
6.4.2.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.2.4.2. Y-o-Y Growth (%), 2017-2025
6.4.2.2.4.3. Market Share (%), 2017-2025
6.4.2.2.5. Clinical Chemistry Technologies
6.4.2.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.2.5.2. Y-o-Y Growth (%), 2017-2025
6.4.2.2.5.3. Market Share (%), 2017-2025
6.4.2.2.6. BPS Analysis of Endocrine Testing Market By Technology
6.4.2.2.7. Market Attractiveness of Endocrine Testing MarketBy Technology
 
6.4.2.3. Europe Endocrine Testing Market Analysis, By Disorder Categories
6.4.2.3.1. Adrenocortical Function
6.4.2.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.3.1.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3.1.3. Market Share (%), 2017-2025
6.4.2.3.2. Perturbation Tests
6.4.2.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.3.2.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3.2.3. Market Share (%), 2017-2025
6.4.2.3.3. Diagnostic Profiles
6.4.2.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.3.3.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3.3.3. Market Share (%), 2017-2025
6.4.2.3.4. Thyroid Function
6.4.2.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.3.4.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3.4.3. Market Share (%), 2017-2025
6.4.2.3.5. Hypothalamic and Pituitary Function
6.4.2.3.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.3.5.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3.5.3. Market Share (%), 2017-2025
6.4.2.3.6. Growth and Growth Hormone
6.4.2.3.6.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.3.6.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3.6.3. Market Share (%), 2017-2025
6.4.2.3.7. Metabolic and Gastrointestinal Disorders
6.4.2.3.7.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.3.7.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3.7.3. Market Share (%), 2017-2025
6.4.2.3.8. BPS Analysis of Endocrine Testing Market By Disorder Categories
6.4.2.3.9. Market Attractiveness of Endocrine Testing Market By Disorder Categories
 
6.4.2.4. Europe Endocrine Testing Market Analysis, By End Users 
6.4.2.4.1. Hospitals/Critical Care Centers
6.4.2.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.4.1.2. Y-o-Y Growth (%), 2017-2025
6.4.2.4.1.3. Market Share (%), 2017-2025
6.4.2.4.2. Diagnostics Labs
6.4.2.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.4.2.2. Y-o-Y Growth (%), 2017-2025
6.4.2.4.2.3. Market Share (%), 2017-2025
6.4.2.4.3. Research Laboratories
6.4.2.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.2.4.3.2. Y-o-Y Growth (%), 2017-2025
6.4.2.4.3.3. Market Share (%), 2017-2025
6.4.2.4.4. BPS Analysis of Endocrine Testing Market By End User
6.4.2.4.5. Market Attractiveness of Endocrine Testing MarketBy End User
 
6.4.3. Asia PacificEndocrine Testing Market Outlook, 2017-2025
 
6.4.3.1. Asia PacificEndocrine Testing Market Analysis, By Country
6.4.3.1.1. China Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.2.  Japan Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.3.  India Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.4.  SingaporeEndocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.5.  Malaysia Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.6.  Thailand Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.7. Australia Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.8.  New Zealand Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.9.  Rest of APAC Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.3.1.10. BPS Analysis of Endocrine Testing Market By Country
6.4.3.1.11. Market Attractiveness of Endocrine Testing MarketBy Country
 
6.4.3.2. Asia Pacific Endocrine Testing Market Analysis, By Technology 
6.4.3.2.1. Tandem Mass Spectrometry 
6.4.3.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.2.1.2. Y-o-Y Growth (%), 2017-2025
6.4.3.2.1.3. Market Share (%), 2017-2025
6.4.3.2.2. Immunoassay
6.4.3.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.2.2.2. Y-o-Y Growth (%), 2017-2025
6.4.3.2.2.3. Market Share (%), 2017-2025
6.4.3.2.3. Monoclonal and Polyclonal Antibody Technologies
6.4.3.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.2.3.2. Y-o-Y Growth (%), 2017-2025
6.4.3.2.3.3. Market Share (%), 2017-2025
6.4.3.2.4. Sensor Technologies
6.4.3.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.2.4.2. Y-o-Y Growth (%), 2017-2025
6.4.3.2.4.3. Market Share (%), 2017-2025
6.4.3.2.5. Clinical Chemistry Technologies
6.4.3.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.2.5.2. Y-o-Y Growth (%), 2017-2025
6.4.3.2.5.3. Market Share (%), 2017-2025
6.4.3.2.6. BPS Analysis of Endocrine Testing Market By Technology
6.4.3.2.7. Market Attractiveness of Endocrine Testing MarketBy Technology
 
6.4.3.3. Asia Pacific Endocrine Testing Market Analysis, By Disorder Categories
6.4.3.3.1. Adrenocortical Function
6.4.3.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.3.1.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3.1.3. Market Share (%), 2017-2025
6.4.3.3.2. Perturbation Tests
6.4.3.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.3.2.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3.2.3. Market Share (%), 2017-2025
6.4.3.3.3. Diagnostic Profiles
6.4.3.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.3.3.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3.3.3. Market Share (%), 2017-2025
6.4.3.3.4. Thyroid Function
6.4.3.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.3.4.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3.4.3. Market Share (%), 2017-2025
6.4.3.3.5. Hypothalamic and Pituitary Function
6.4.3.3.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.3.5.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3.5.3. Market Share (%), 2017-2025
6.4.3.3.6. Growth and Growth Hormone
6.4.3.3.6.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.3.6.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3.6.3. Market Share (%), 2017-2025
6.4.3.3.7. Metabolic and Gastrointestinal Disorders
6.4.3.3.7.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.3.7.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3.7.3. Market Share (%), 2017-2025
6.4.3.3.8. BPS Analysis of Endocrine Testing Market By Disorder Categories
6.4.3.3.9. Market Attractiveness of Endocrine Testing Market By Disorder Categories
 
6.4.3.4. Asia Pacific Endocrine Testing Market Analysis, By End Users 
6.4.3.4.1. Hospitals/Critical Care Centers
6.4.3.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.4.1.2. Y-o-Y Growth (%), 2017-2025
6.4.3.4.1.3. Market Share (%), 2017-2025
6.4.3.4.2. Diagnostics Labs
6.4.3.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.4.2.2. Y-o-Y Growth (%), 2017-2025
6.4.3.4.2.3. Market Share (%), 2017-2025
6.4.3.4.3. Research Laboratories
6.4.3.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.3.4.3.2. Y-o-Y Growth (%), 2017-2025
6.4.3.4.3.3. Market Share (%), 2017-2025
6.4.3.4.4. BPS Analysis of Endocrine Testing Market By End User
6.4.3.4.5. Market Attractiveness of Endocrine Testing MarketBy End User
 
6.4.4. Latin America Endocrine Testing Market Outlook, 2017-2025
 
6.4.4.1. Latin America Endocrine Testing Market Analysis, By Country
6.4.4.1.1. Brazil Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.4.1.2. MexicoEndocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.4.1.3. Rest of Latin America Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025) 
6.4.4.1.4. BPS Analysis of Endocrine Testing Market By Country
6.4.4.1.5. Market Attractiveness of Endocrine Testing MarketBy Country
 
6.4.4.2. Latin America Endocrine Testing Market Analysis, By Technology 
6.4.4.2.1. Tandem Mass Spectrometry 
6.4.4.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.2.1.2. Y-o-Y Growth (%), 2017-2025
6.4.4.2.1.3. Market Share (%), 2017-2025
6.4.4.2.2. Immunoassay
6.4.4.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.2.2.2. Y-o-Y Growth (%), 2017-2025
6.4.4.2.2.3. Market Share (%), 2017-2025
6.4.4.2.3. Monoclonal and Polyclonal Antibody Technologies
6.4.4.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.2.3.2. Y-o-Y Growth (%), 2017-2025
6.4.4.2.3.3. Market Share (%), 2017-2025
6.4.4.2.4. Sensor Technologies
6.4.4.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.2.4.2. Y-o-Y Growth (%), 2017-2025
6.4.4.2.4.3. Market Share (%), 2017-2025
6.4.4.2.5. Clinical Chemistry Technologies
6.4.4.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.2.5.2. Y-o-Y Growth (%), 2017-2025
6.4.4.2.5.3. Market Share (%), 2017-2025
6.4.4.2.6. BPS Analysis of Endocrine Testing Market By Technology
6.4.4.2.7. Market Attractiveness of Endocrine Testing MarketBy Technology
 
6.4.4.3. Latin America Endocrine Testing Market Analysis, By Disorder Categories
6.4.4.3.1. Adrenocortical Function
6.4.4.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.3.1.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3.1.3. Market Share (%), 2017-2025
6.4.4.3.2. Perturbation Tests
6.4.4.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.3.2.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3.2.3. Market Share (%), 2017-2025
6.4.4.3.3. Diagnostic Profiles
6.4.4.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.3.3.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3.3.3. Market Share (%), 2017-2025
6.4.4.3.4. Thyroid Function
6.4.4.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.3.4.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3.4.3. Market Share (%), 2017-2025
6.4.4.3.5. Hypothalamic and Pituitary Function
6.4.4.3.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.3.5.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3.5.3. Market Share (%), 2017-2025
6.4.4.3.6. Growth and Growth Hormone
6.4.4.3.6.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.3.6.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3.6.3. Market Share (%), 2017-2025
6.4.4.3.7. Metabolic and Gastrointestinal Disorders
6.4.4.3.7.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.3.7.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3.7.3. Market Share (%), 2017-2025
6.4.4.3.8. BPS Analysis of Endocrine Testing Market By Disorder Categories
6.4.4.3.9. Market Attractiveness of Endocrine Testing Market By Disorder Categories
 
6.4.4.4. Latin America Endocrine Testing Market Analysis, By End Users 
6.4.4.4.1. Hospitals/Critical Care Centers
6.4.4.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.4.1.2. Y-o-Y Growth (%), 2017-2025
6.4.4.4.1.3. Market Share (%), 2017-2025
6.4.4.4.2. Diagnostics Labs
6.4.4.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.4.2.2. Y-o-Y Growth (%), 2017-2025
6.4.4.4.2.3. Market Share (%), 2017-2025
6.4.4.4.3. Research Laboratories
6.4.4.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.4.4.3.2. Y-o-Y Growth (%), 2017-2025
6.4.4.4.3.3. Market Share (%), 2017-2025
6.4.4.4.4. BPS Analysis of Endocrine Testing Market By End User
6.4.4.4.5. Market Attractiveness of Endocrine Testing MarketBy End User
 
6.4.5. Middle East & Africa Endocrine Testing Market Outlook, 2017-2025
 
6.4.5.1. Middle East & Africa Endocrine Testing Market Analysis, By Country
6.4.5.1.1. GCC Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.5.1.2.  North Africa Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.4.5.1.3.  South Africa Endocrine Testing Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025) 
6.4.5.1.4. BPS Analysis of Endocrine Testing Market By Country
6.4.5.1.5. Market Attractiveness of Endocrine Testing MarketBy Country
 
6.4.5.2. Middle East & Africa Endocrine Testing Market Analysis, By Technology 
6.4.5.2.1. Tandem Mass Spectrometry 
6.4.5.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.2.1.2. Y-o-Y Growth (%), 2017-2025
6.4.5.2.1.3. Market Share (%), 2017-2025
6.4.5.2.2. Immunoassay
6.4.5.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.2.2.2. Y-o-Y Growth (%), 2017-2025
6.4.5.2.2.3. Market Share (%), 2017-2025
6.4.5.2.3. Monoclonal and Polyclonal Antibody Technologies
6.4.5.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.2.3.2. Y-o-Y Growth (%), 2017-2025
6.4.5.2.3.3. Market Share (%), 2017-2025
6.4.5.2.4. Sensor Technologies
6.4.5.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.2.4.2. Y-o-Y Growth (%), 2017-2025
6.4.5.2.4.3. Market Share (%), 2017-2025
6.4.5.2.5. Clinical Chemistry Technologies
6.4.5.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.2.5.2. Y-o-Y Growth (%), 2017-2025
6.4.5.2.5.3. Market Share (%), 2017-2025
6.4.5.2.6. BPS Analysis of Endocrine Testing Market By Technology
6.4.5.2.7. Market Attractiveness of Endocrine Testing MarketBy Technology
 
6.4.5.3. Middle East & Africa Endocrine Testing Market Analysis, By Disorder Categories
6.4.5.3.1. Adrenocortical Function
6.4.5.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.3.1.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3.1.3. Market Share (%), 2017-2025
6.4.5.3.2. Perturbation Tests
6.4.5.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.3.2.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3.2.3. Market Share (%), 2017-2025
6.4.5.3.3. Diagnostic Profiles
6.4.5.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.3.3.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3.3.3. Market Share (%), 2017-2025
6.4.5.3.4. Thyroid Function
6.4.5.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.3.4.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3.4.3. Market Share (%), 2017-2025
6.4.5.3.5. Hypothalamic and Pituitary Function
6.4.5.3.5.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.3.5.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3.5.3. Market Share (%), 2017-2025
6.4.5.3.6. Growth and Growth Hormone
6.4.5.3.6.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.3.6.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3.6.3. Market Share (%), 2017-2025
6.4.5.3.7. Metabolic and Gastrointestinal Disorders
6.4.5.3.7.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.3.7.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3.7.3. Market Share (%), 2017-2025
6.4.5.3.8. BPS Analysis of Endocrine Testing Market By Disorder Categories
6.4.5.3.9. Market Attractiveness of Endocrine Testing Market By Disorder Categories
 
6.4.5.4. Middle East & Africa Endocrine Testing Market Analysis, By End Users 
6.4.5.4.1. Hospitals/Critical Care Centers
6.4.5.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.4.1.2. Y-o-Y Growth (%), 2017-2025
6.4.5.4.1.3. Market Share (%), 2017-2025
6.4.5.4.2. Diagnostics Labs
6.4.5.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.4.2.2. Y-o-Y Growth (%), 2017-2025
6.4.5.4.2.3. Market Share (%), 2017-2025
6.4.5.4.3. Research Laboratories
6.4.5.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025
6.4.5.4.3.2. Y-o-Y Growth (%), 2017-2025
6.4.5.4.3.3. Market Share (%), 2017-2025
6.4.5.4.4. BPS Analysis of Endocrine Testing Market By End User
6.4.5.4.5. Market Attractiveness of Endocrine Testing MarketBy End User
 
7. Competitive Analysis
7.1. Company Profiles of Major Players
7.1.1. Thermo Fisher Scientific 
7.1.1.1. Financial Analysis
7.1.1.2. Business Strategy
7.1.1.3. Product Portfolio
7.1.1.4. Global Presence
7.1.2. Quest Diagnostics
7.1.3. BioMerieux
7.1.4. Siemens Healthcare
7.1.5. Abbott Laboratories
7.1.6. Ortho Clinical Diagnostics
7.1.7. Agilent Technologies
7.1.8. Biomedical Diagnostics
7.1.9. Bio-Rad Laboratories, Inc.
7.1.10. AB Sciex Pte. Ltd.
7.1.11. F. Hoffmann-La Roche Ltd.
7.1.12. DiaSorinS.p.A.
7.1.13. Quest Technology
7.1.14. Sysmex Corporation
7.1.15. Laboratory Corporation of America Holdings (LabCorp)
 
8. Porter’s Five Force Model
 
9. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem 
 
10. Expert Analysis
 
11. Concluding Remarks

Endocrine Testing Market: By Technology (Tandem Mass Spectrometry, Immunoassay, Monoclonal, Sensor & Clinical Chemistry Technologies), By Disorder Categories, By End User

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747